HCM
ALIM

Highbridge Capital Management’s Alimera Sciences ALIM Stock Holding History

Highbridge Capital Management’s Portfolio ALIM Stock Details ALIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-851
Closed -$70K – 1629
2014
Q4 		$70K Sell
851
-526
-38% -$42.7K ﹤0.01% 1117
2014
Q3 		$112K Buy
+1,377
New +$118K ﹤0.01% 1142

Other funds holding ALIM

SM
Scale Management Foster City, California $359M AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PVMCI
Polaris Venture Management Co IV Boston, Massachusetts $62.4M AUM 33.04% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
NRC
North Run Capital Boston, Massachusetts $43.5M AUM 38.24% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

Highbridge Capital Management's ALIM Position: Q1 2015 in Review

Highbridge Capital Management sold out of Alimera Sciences (ALIM) in Q1 2015, closing a stake of 851 shares — an estimated $70K sold.

Highbridge Capital Management first reported a position in ALIM in Q3 2014 and held it in 2 quarters. The position peaked at $112K in Q3 2014. 64 funds tracked by Wall St. Rank hold ALIM as of Q1 2015.

  • Highbridge Capital Management reported no remaining Alimera Sciences position as of Q1 2015 after selling out during the quarter.
  • Highbridge Capital Management sold 851 Alimera Sciences shares in Q1 2015, an estimated $70K.
  • Highbridge Capital Management first reported a position in Alimera Sciences in Q3 2014 and held it in 2 quarters.
  • Highbridge Capital Management's Alimera Sciences position peaked at $112K in Q3 2014.
  • 64 funds tracked by Wall St. Rank held Alimera Sciences as of Q1 2015.

Based on Highbridge Capital Management's 13F filing for Q1 2015, filed 15 May 2015.